INTRODUCTION
Experimental work in animal models strongly suggests that CD4ϩ T helper cell type 1 (Th1)-mediated immunity is crucial in immunosurveillance and protection against the opportunistic pathogen Candida albicans [1, 2] . This notion is also indirectly supported by the observation that almost all healthy human individuals exhibit robust Candida-specific Th1-type immune responses and may safely harbor the fungus as a commensal in the gastrointestinal and other mucocutaneous tracts [3, 4] . Consequently, impaired antifungal T cell immunity is a major predisposing factor to severe mucosal candidiasis, such as those occurring in AIDS patients [5] . Conversely, disseminated forms of candidiasis are mostly associated with neutropenia, but T cell immunity clearly regulates defense mechanisms involved in systemic anti-Candida protection through phagocyte activation and help for production of protective antibodies [1, 6] .
Initiation and maintainance of specific T cell responses strictly rely on the interaction of the fungus with professional antigen-presenting cells (APCs). Among them, dendritic cells (DCs) are particularly efficient in priming and expanding Candida-specific T lymphocytes in the inductive sites of the immune system [7, 8] . Immature DCs patrol peripheral tissues at potential sites of pathogen entry. Upon exposure to microbial pathogens and/or to signals from infected tissues, these cells can undergo maturation into potent T cell-stimulatory and migratory effector DCs, capable of activating naïve T cells in draining lymph nodes [7, 8] . During maturation, sentinel DCs are able to decode and integrate pathogen-and environmentderived information, thus acquiring not only the ability of triggering an immune response but also the competence for a fine regulation of the amplitude or the class of the response to be evoked in T cells [7, 9] . In this process, the nature of the DC-interacting pathogen plays an important role. In fact, it is increasingly evident that distinct microbial pathogens (or microbial products) can drive the development of qualitatively different T cell-immune responses through directly priming sentinel DCs into effector DCs with diverse, functional phenotypes and Th-directing ability [1, 9 -12] .
Interactions of human DCs with C. albicans and their consequences in terms of initiation of T cell immunity against this important human pathogen have been only marginally studied. Newman and Holly [13] reported that in vitro-differentiated human DCs can phagocytose and kill unopsonized yeast (Y) cells of C. albicans, becoming able to activate memory T lymphocytes from autologous, Candida-sensitized individuals. In this study, however, no attempt was made to assess whether Candida-pulsed DCs also acquired the ability to prime naive T cells for a primary response nor to discriminate the responses generated in DCs by the different forms of growth of the fungus. These latter issues appear to be of major relevance, as the ability of C. albicans to convert in vivo from the Y to the hyphal (H) habit of growth has long been associated with the transition from commensalism to virulence [14 -16] . Y-to-H switch is initiated, in vivo or in vitro, by the emergence of short H protrusions, usually referred to as germ-tubes (GT), which are considered a critical, transitional stage for host invasion by the fungus [15, 16] .
Overall, a positive correlation between the ability to develop GT and the experimental pathogenicity of the fungus has been postulated by several authors [14, 16] , but the actual role of the morphology switch for Candida virulence in humans is still debated, as most of the correlations between form of growth and virulence have been established in experimental models of rodents, which are not, as are humans, persistently colonized by the fungus [15] . Formation of GT/H cells has repeatedly been suggested to contribute to the pathogenesis of Candida infections by fostering immune evasion or immune deviation [1, [17] [18] [19] . In particular, in a murine model of invasive fungal infection, H-form Candida cells were shown to selectively prime the nonprotective host's immunity by means of modulation of DC differentiation and functions [20] . In fact, murine splenic DCs produced interleukin (IL)-12 and induced protective anti-Candida Th1-type immunity when activated by the Y form, whereas they produced IL-4 and promoted initiation of inefficacious Th2-type T cell responses when activated by the H form [20] .
In human candidiasis, the ability to modulate human underlying T cell immunity through interaction with DCs might be instrumental to the fungus in favoring its persistence at infection sites. Several authors have indeed suggested an association between Th2-biased antifungal responses at a systemic or local level and severe or recurrent Candida infections [21] [22] [23] . Moreover, Candida-induced dysregulation or impairment of specific Th1 reactivity has been proposed to occur in concomitance with severe, disseminated infections such as chronic mucocutaneous candidiasis or Candida sepsis [24, 25] .
These observations prompted us to examine whether the distinct, fungal forms could induce different functional patterns in human DCs. We therefore investigated the functional activities of human monocyte-derived DCs exposed to Y or GT cells of C. albicans in an experimental in vitro model, mimicking the encounter of human immature, tissue-resident DCs with the fungus. Our results unambiguously demonstrated that human DCs can efficiently phagocytose and kill Y and GT forms of Candida; upon ingestion of either form, DCs undergo a full maturation process; and Y-and GT-activated DCs, as well as DCs activated by elongated H cells, acquire the ability to prime naive T lymphocytes with a defined Th1 phenotype.
MATERIALS AND METHODS

Reagents
Granulocyte macrophage-colony stimulating factor (GM-CSF; Leucomax) was purchased from Sandoz (Basel, Switzerland) and IL-4, from R&D Systems (Minneapolis, MN). 
Media
RPMI 1640 (Euroclone Ltd., UK) was used, supplemented with 100 U/ml kanamycin, 1 mM L-glutamine, 1 mM sodium pyruvate, 1% nonessential amino acids, and 10% fetal calf serum (FCS; Hyclone, Logan, UT; complete medium). Where indicated, FCS was replaced with 5% human serum (Sigma Chemical Co.).
Fungal cells
Live Y, GT, and H cells were obtained, as described previously [19] , from the H conversion-competent strain BP, maintained in the established type collection of the Istituto Superiore di Sanità (Rome, Italy). Briefly, Y cells, grown in Winge medium for 24 h at 28°C, were washed in saline, resuspended at a density of 2 ϫ 10 6 cells/ml in buffered Lee's medium, and incubated at 28°C or 37°C. At 28°C, fungal cells maintained the Y form, whereas at 37°C, more than 90% Y cells produced, within ϳ60 min, a short, H protrusion, as long or twice as long as the Y cell of origin (GT), which grew in the following 3 h of incubation, developing into H cells, five to seven times longer than the Y cell of origin. Y, GT, and H cells were harvested by centrifugation, washed twice with phosphate-buffered saline (PBS), and resuspended in PBS at the desired concentration.
DC-C. albicans cocultures
Peripheral blood mononuclear cells were purified from heparinized blood on a density gradient (Lymphoprep, Nycomed Pharma AS, Oslo, Norway), as described previously [26] , and were resuspended in PBS ϩ 10% FCS. Monocytes were positively sorted using anti-CD14-labeled magnetic beads (MACS, Miltenyi, Germany), according to the manufacturer's instructions. Freshly isolated monocytes were resuspended in complete medium ϩ FCS 10%, containing GM-CSF (200 U/ml) and IL-4 (100 U/ml) at 4 ϫ 10 5 cell/ml, and were cultured in six-well culture plates at 3 ml/well for 5 days. Suspensions of live C. albicans cells were then added to the cultures at the DC:Candida ratio indicated in single experiments. To prevent Candida overgrowth, Am B (0.62 g/ml) was also added to the cultures, 30 min after Candida pulsing. Control DC cultures were treated with Am B only or with Am B plus 0.1 g/ml lipopolysaccharide (LPS). Phagocytosis of C. albicans cells by DCs was evaluated in each experiment by periodic acid-Schiff (PAS) staining of formaldehyde-fixed cytospin preparations from parallel cultures.
Evaluation of phagocytosis and killing of C. albicans by DCs
Phagocytosis was measured as inhibition of [ 3 H] glucose uptake by Y or GT cells upon ingestion by DCs, as described previously [17] . Briefly, triplicate cocultures of Y or GT cells with DCs (10 6 /ml), at a DC:Candida ratio of 1:4, were prepared in complete medium without Am B and incubated 45 min at 37°C, 5% CO 2 , to allow phagocytosis of fungal cells by DCs. Uninternalized Candida cells were then labeled with [ 3 H] glucose for 1 h. Percent phagocytosis was calculated by comparing the radiolabel incorporation by fungal cells cultured with DCs with the incorporation by control Y or GT cells cultured without DCs.
Killing of the different fungal forms was evaluated in triplicate cocultures, in the same medium as above, at a DC:Candida ratio of 10:1 or 5:1, upon a 4-h interaction [21] . DCs were then lysed with 0.2% Triton X-100, and survived fungal cells were enumerated by colony-forming unit (CFU) counts. Percent killing was calculated by comparing CFU counts from Candida:DC cocultures with CFU from cultures of Y and GT alone.
Fluorescein-activated cell sorter (FACS) analysis
Cells were stained with the following antibodies: anti-human leukocyte antigen (HLA) class I, HLA class II, CD1a, CD14, CD25, CD40, CD80, CD83, and CD86 and with the antichemokine receptor antibodies anti-CCR5, CXCR4, and CCR7, all purchased from PharMingen (San Diego, CA). Viability of cells was evaluated by propidium iodide (PI) staining (Sigma Chemical Co.). Human-adsorbed, fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse immunogobulin G (IgG) and goat anti-mouse IgM (Southern Biotechnology Associates, Birmingham, AL) were used as the secondary antibodies. Staining of intracellular cytokines in T cells following stimulation with DCs was performed using phycoerythrin-conjugated rat anti-human IL-4 or IL-10 and FITC-conjugated mouse anti-human interferon-␥ (IFN-␥) or IL-2 in peridinin chlorophyll protein-conjugate CD3 ϩ cells (PharMingen) after fixation and permeabilization of cells with Cytofix/Cytoperm™ (PharMingen), according to the manufacturer's instructions. Stained cells were analyzed by flow cytometry using a FACScan cytometer (Becton Dickinson, Mountain View, CA) using Cellquest Software (Becton Dickinson). PI was used to exclude dead cells.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
PolyA ϩ RNA was extracted from immature, control DCs or from Candida-or LPS-treated cells (1ϫ10 6 ), using the Micro-FastTrack 2.0 kit (Invitrogen, San Diego, CA), according to the manufacturer's instructions, and reverse-transcribed as described previously [19] . Aliquots of cDNA yielding equivalent amounts of ␤-actin-amplified band were used for the semiquantitative evaluation of cytokine gene expression. PCR was performed in a 10-l vol in a Perkin-Elmer 9600 thermal cycler. Cytokine-specific primer pairs were synthesized by Gibco-BRL, according to published sequences [26 -31] , and amplification conditions were chosen accordingly. The PCR products were visualized by electrophoresis and ethidium-bromide staining and were identified by their expected molecular size.
Antigen-presentation ability and priming of naïve T cells by DCs
Decreasing numbers of immature DCs, LPS-matured DCs, and Candidatreated DCs were assayed for their capacity to induce proliferation of autologous, specific, anti-Candida T cell clones (TCC; 5ϫ10 4 cells/well) or allogeneic cord blood lymphocytes (CB-T; 5ϫ10 4 cells/well). In some experiments with TCC, DCs pulsed with decreasing numbers of Y or GT cells were compared with DCs loaded with specific fungal antigens and matured by LPS treatment. The assays were performed in complete medium supplemented with 5% human AB serum. Generation and characterization of anti-Candida TCC have been reported elsewhere [4] . The proliferative response was measured on day 5 by a 16-h pulse with [ 3 H] thymidine. To examine the functional polarization induced in naive T lymphocyte by immature DCs, LPS-treated DCs, and Y-, GT-, or H-pulsed DCs, these cells were cultured for 7 days with CB-T. Intracellular staining for cytokine production by T cells was performed after stimulation of T cells for 5 h with 10 Ϫ7 M PMA and 0.5 g/ml ionomycin in the presence of brefeldin at 2 g/ml. For cytokine determination in the supernatants, parallel cultures were stimulated as described in the absence of brefeldin.
Cytokine determination
Culture supernatants from DC-Candida cocultures or from cultures of control or LPS-matured DCs were collected at 7, 18, or 48 h after the administration of fungal cells or LPS. Supernatants of CB-T cells were obtained as described above. Supernatants were frozen until use. Cytokine secretion [IL-10, IL12p70, and transforming growth factor-␤ (TGF-␤)] was determined using commercially available kits (R&D Systems), according to the manufacturer's instructions, and were expressed in pg/ml.
Statistics
The data were assessed for statistical significance by two-tailed Student's t-test or nonparametric Mann-Whitney U-test, as appropriate. Statistical significance was set at P Ͻ 0.05.
RESULTS
Phagocytosis and killing of C. albicans by human DCs
In a first series of experiments, we tested, in comparison, the ability of DCs to phagocytose and kill Y or GT cells of C. albicans. We observed that DCs efficiently ingested both fungal forms. In fact, the mean Ϯ SD percent fungal cells ingested by DCs, measured at 2 h in three independent, triplicate experiments at an effector:target (E:T) ratio of 1:4, were 87 Ϯ 16 and 57 Ϯ 12 for Y or GT cells, respectively. Microscope examination of PAS-stained Y-or GT-DC cocultures, at E:T ratios ranging from 1:1 to 1:5, constantly showed that after 18 h of incubation, more than 95% of DCs contained at least one but frequently up to five fungal cells. At lower E:T ratios (1:10), a substantial percentage of fungal cells remained uningested, and further increases of fungal doses were associated to progressively higher DC mortality (data not shown).
As DCs have previously been shown to kill Candida cells by intra-and extracellular mechanisms [13] , we measured fungal killing by a classical plate-counting assay designed to measure intra-and extracellular killing at the same time. Enumeration of Candida CFU after a 4 h-coincubation with DCs, at an E:T ratio of 10:1, indicated that both fungal forms were markedly killed by DCs (56Ϯ20 and 32Ϯ6 mean percent killingϮSD in three independent, triplicate experiments for Y or GT cells, respectively). Small differences between Y and GT cell susceptibility to phagocytosis and killing by DCs were not statistically significant, as assessed by two-tailed Student's t-test.
Therefore, these experiments indicated that both fungal forms are efficiently internalized and degraded by human DCs.
Antigen presentation ability by Y-and GT-DCs
To evaluate the ability of Y-or GT-pulsed DCs for activation of memory Candida-specific T lymphocytes, we resorted to the use of specific human TCC generated against MP-F2, a purified antigenic preparation containing major immunodominant antigens of the fungus, such as the MP65 mannoprotein [4] . T cells were cocultured with autologous DCs pulsed with increasing concentration of Y or GT cells, and after 5 days of coculture, proliferation was evaluated by [ 3 H] thymidine incorporation. LPS-matured, autologous DCs, pulsed or not with the specific MP-F2 antigen, were used as the positive and the negative control, respectively. As shown in Figure 1 , these experiments confirmed that Y and GT cells were efficiently processed for antigen presentation by DCs and could comparably activate DCs for stimulation of a robust, memory, proliferative response by MP-F2-specific T cells. TCC proliferation induced by Y-or GT-pulsed DCs was comparable with that induced by DCs, which have been loaded with the specific MP-F2 fungal antigen and then induced to mature by LPS treatment, whereas no significant proliferation was triggered by unpulsed, LPS-matured DCs (Fig. 1) .
Phenotypic characterization of Candida-simulated DCs
We next investigated whether the phagocytosis of Candida cells could trigger the process of DC maturation by analyzing DC phenotype after an overnight cocultivation with Y or GT cells. The interaction with both fungal forms, at a DC:Candida ratio of 1:1, induced the expression of the maturation-related surface antigen CD83 at levels comparable with those observed after treatment with bacterial LPS, a potent maturation stimulus for DCs ( Fig. 2A) . However, unlike LPS, neither Y nor GT cells up-regulated CD25, another maturation-related protein ( Fig. 2A) . Y-and GT-treated DCs showed a similarly increased expression of the costimulatory molecules CD80 (B7.1), CD86 (B7.2), and CD40, as well as of HLA class I and II DR molecules (Fig. 2B) . No gross differences in the phenotype displayed by Candida-matured DCs were observed using the two different DC:fungal cell ratios of 1:1 or 1:5 or when live fungal cells were replaced with predifferentiated, heat-inactivated (30 min, 80°C) Y or GT cells, in the absence of Am B (data not shown).
Flow cytometric analysis also revealed significant modulations in the expression of distinct chemokine receptors in Candida-or LPS-matured DCs as compared with immature cells. All stimulants induced a marked up-regulation of CCR7, in concomitance with down-regulation of CCR5 expression (Fig. 2C) . It is interesting that the chemokine receptor CXCR4 was up-regulated only upon Candida-induced maturation and only weakly increased or not increased at all upon maturation with LPS.
Cytometric analysis, therefore, indicated that the interaction with C. albicans induced DCs to express a full array of phenotypic/functional surface markers typical of mature DCs, with no appreciable differences between Y or GT cells.
Pattern of cytokine expression by
Candida-matured DCs
Cytokine production is a major functional aspect of DC maturation and differentiation and critically impacts on the ability of DCs to activate and prime T cells. Therefore, we analyzed the profile of cytokine expression induced in DCs by stimulation with Y or GT cells in comparison with LPS.
RT-PCR analysis of cytokine mRNA expression after o.n. stimulation with Candida cells (Fig. 3A) showed that Ymatured DCs expressed abundant IL-12p40 but only scarce IL-10 mRNA transcripts. In contrast, GT-matured DCs expressed substantial levels of IL-12p40 and IL-10 transcripts. The two fungal forms induced similar TNF-␣ and low IL-6 expression, whereas GT cells appeared to be more efficient than Y cells in eliciting the chemokines IL-8 and MIP-1␣ (Fig.  3A) . Similar to LPS, both Candida forms markedly downregulated TGF-␤1 mRNA expression. No expression of IFN-␣ or IL-4 mRNAs was observed following stimulation of DCs with Y or GT cells or with LPS (data not shown).
In these experiments, we also observed a sustained transcription of the CCR7 gene in Candida-and LPS-matured DCs, thus confirming the results obtained by flow cytometric analysis (Fig. 3A) .
Following these results, we compared more in detail Y and GT cells for their ability to stimulate the release of the Th1-related IL-12p70 and of the regulatory IL-10 cytokine. In dose-response experiments (Fig. 3B) , the two forms were found almost equally efficient in eliciting a strong IL-12 response by DCs, whereas the IL-10 protein was detected in the supernatants of GT-matured DCs at severalfold higher concentrations than in supernatants of Y-matured DCs, in particular, when a high number of fungal cells were administered to DCs. A similar kinetics of cytokine accumulation in supernatants of Candida-DC cocultures was seen after stimulation of DCs with Y or GT Candida cells. IL-12 and IL-10 were at low/undetectable levels 8 h after the administration of fungal cells; peak release of both cytokines occurred within 8 and 18 h, and their concentrations only moderately increased in the following 30 h of coincubation (data not shown).
A direct comparison of IL-12 and IL-10 levels following treatment with Y and GT cells in DCs from four different subjects is given in Figure 3C . As Y cells, but not H cells, are able to trigger IL-12 production by purified, murine, splenic DCs [20] and as GT cells are only in the initial phase of Y-to-H transition, we also assayed for IL-12 and IL-10 production by DCs upon activation by fully elongated H cells. Although with donor-dependent, quantitative variations, DCs produced substantial levels of IL-12 in response to any type of fungal form and no significant differences among Y, GT, or H cells, as assessed by the two-tailed Mann-Whitney U test (Fig. 3C) . Conversely and similarly to that observed in dose-response experiments, GT and H cells reproducibly triggered, in the DCs from the same donors, an IL-10 production significantly higher than that induced by Y cells (mean pg/ml SEM: 32ϩ15, 296ϩ109, and 327ϩ132 for Y-, GT-or H-stimulated DCs, respectively; PϽ0.05 comparing Y cells with GT or H cells, Mann-Whitney U test; Fig. 3C ).
On the whole, these experiments indicated that Y-and GTor H-cell-driven DC activation was associated with release/ expression of several immunomodulatory cytokines and that the distinct fungal forms, although triggering comparable IL-12 responses by DCs, displayed some differences in the pattern of cytokine induction; in particular, the production of IL-10 was preferentially stimulated by the GT/H forms.
APC functions of C. albicans, matured DCs
Functional assays were then performed to evaluate whether Yand GT-matured DCs were capable of stimulating naive T lymphocytes for a primary response and to characterize the type of functional polarization induced in T cells by these DCs. We again included in these experiments DCs stimulated with H cells, as it has been previously reported that this form, different from the Y form, selectively primes murine DCs with the ability to trigger Th2-type responses in vivo [20] .
When allogeneic CB-T were cultured with Y-, GT-, or Hactivated DCs, T cell proliferation was significantly stimulated, irrespective of the fungal form used for DC activation (Fig.  4A) . It is interesting that the proliferative responses induced in CB-T by Y-or GT-matured DCs were always higher than those induced by LPS-matured DCs, as four-to eightfold fewer Y-or GT-DCs were required to trigger the same levels of proliferation stimulated by LPS-DCs (Fig. 4A) . In comparison to Y-or GT-activated DCs, H-DCs were found to be less efficient in inducing proliferation by T cells. Nevertheless, the proliferation levels stimulated by these DCs were totally comparable with those induced by LPS-matured DCs (Fig. 4A) .
More importantly, flow cytometric analysis of intracellular cytokine accumulation in proliferating CB-T lymphocytes showed that Y-or GT-and even H-matured DCs induced in naïve T cells culture an equivalent number of cells expressing IFN-␥ or IL-2 (Fig. 4B) . Levels of IFN-␥ and IL-2 accumulation in CB-T stimulated by Candida-DCs were always comparable with those induced by LPS-matured DCs (Fig. 4B) . In addition, no significant percentage of T cells preferentially producing IL-4 or IL-10, suggestive of a Th2-type polarization or T regulatory cell (Treg) induction, was found by FACS analysis (Fig. 4B ). In line with this finding, similar, low levels of IL-10 were measured in supernatants from lymphocyte cultures stimulated by Candida-or LPS-DCs (66Ϯ12, 41Ϯ14, 37Ϯ14, and 44Ϯ9 mean pg/mlϮSE in three independent experiments for CB-T stimulated by Y-, GT-, H-, or LPS-DCs, respectively), and no significant production of TGF-␤ was observed in CB-T cell-culture supernatants, as determined by enzyme-linked immunosorbent assay (data not shown). Lastly, Altogether, these findings indicated that CB-T lymphocytes stimulated with Y-, GT-, or H-matured DCs undergo a definiteTh1-type polarization.
DISCUSSION
No specific or detailed investigation on the activation of human DCs by the dimorphic fungus C. albicans has been addressed, despite the importance of DCs for initiation and maintanance of the protective immunosurveillance, which in the immunocompetent host, hampers tissue invasion by this opportunistic pathogen. In an attempt to fill this gap, we comparatively examined responses generated in DCs upon activation with Y and GT cells of the fungus, in consideration of the supposed, differential role of the two forms in fungal virulence and immunoevasion [14 -20] .
Initiation of an antifungal response by DCs requires active internalization of fungal cells and/or antigens and processing in vacuolar compartments to allow generation of major histocompatibility complex (MHC)-antigen complexes to be presented to T cells on the surface of DCs [32] . Although DCs are capable of rapidly ingesting numerous microbial pathogens, their ability to kill and degrade microbial cells is extremely variable, depending on the nature of the DC itself and the specific microbial target [33] .
Human monocytes/macrophages and neutrophils internalize with different efficiency Y and GT/H cells of C. albicans, being the GT/H forms particularly refractory to phagocytosis [19, 34, 35] . Preferential efficacy of different fungicidal mechanisms against the two fungal forms and partial resistance of GT/H cells to phagocyte killing have also been described [36, 37] 
or GT cells was actually ingested and killed by immature DCs. This suggests that DCs can exert an even higher anticandidal activity as compared with other human phagocytic effectors. Overall, our results confirm and extend recent studies showing that human DCs are more potently phagocytic and fungicidal than macrophages against Y cells of C. albicans and other important fungal pathogens, such as Histoplasma capsulatum [16, 38] . They also indicate that both fungal forms, upon DC encounter, may undergo extensive and comparable antigen processing for MHC II/MHC I presentation.
In analogy with other microorganism [33] , interaction with Candida cells triggered DC maturation and activation, as indicated by the increased expression of several maturationassociated surface markers and costimulatory molecules involved in antigen presentation and T cell stimulation [7] [8] [9] [10] . Candida-driven maturation was also accompanied by downmodulation of CCR5 and substantially increased surface expression of CXCR4 and CCR7 chemokine receptors, suggesting that upon Candida encounter, DCs acquire the competence for colocalization with T cells in secondary lymphoid organs [39, 40] .
We did not observe any gross difference in the phenotypic profiles displayed by Y-or GT-matured DCs. Instead, Candida-matured DCs showed some differences from LPS-matured DCs. These differences, however, are not surprising, considering that fungal pathogen-associated molecular patterns (PAMPs) possibly involved in Candida-driven DC maturation (mannan/␤-glucan) are quite different from LPS, in molecular nature and in receptor specificity [36] . Candida cells, but not LPS, up-regulated the surface expression of CXCR4, a chemokine receptor that has been involved in promoting colocalizion of DCs with naive T and B cells in lymphoid tissues [39, 40] . Conversely, the CD25 antigen, a maturation-associated molecule that is up-regulated upon LPS-and bacterial-induced DC activation [37] , was not expressed by Candida-matured DCs. In murine models, expression of CD25 (␣ chain of IL-2 receptor) by mature DCs has been suggested to link the functional fate of these cells to the activation of T lymphocytes during antigen presentation [38] . However, possible functional consequences deriving from low expression of this receptor on Candidamatured DCs cannot be fully appreciated, as biological activity and functions of CD25 in human DCs are still uncertain.
It is of interest that maturation induced by Y or GT Candida cells triggered a different pattern of cytokine expression by DCs. The most remarkable difference was that GT-matured DCs produced significantly more elevated amounts of IL-10 as compared with Y-matured DCs, as observed at gene expression and at protein level, and using several different Candida:DC ratios. It is noteworthy that GT cells shared their particular competence for IL-10 induction with fully differentiated H cells. This strengthens the notion that GT forms, although being only the initial phase of H development, are closely similar to H cells, not only in molecular patterns expressed at their surface [41] but also in their interaction with different immunocompetent cells [17] [18] [19] 41] . Differential ability for IL-10 induction also suggests that Y and GT/H forms are differently recognized by human DCs and can activate distinct, downstream signaling events in these cells. Recently, this has been reported to occur in murine DC, as in these DCs, the preferential internalization of Y forms through the mannosefucose receptor (MR) or the prevalent engagement of the Fc receptor for IgG and CR3 receptors for ingestion of H forms induces different activatory patterns, resulting in priming of APCs with different ability for IL-12 production and T cell polarization [36] . Mannan and ␤-glucan fungal PAMPs might mediate differential recognition by DCs, as they can engage distinct phagocytic/activatory receptors [36] and are differently expressed in Y and GT/H cells [19, 41] .
Nevertheless, differential cytokine expression upon stimulation by the distinct Candida forms did not appear to affect DC competence for T cell activation or polarization. In fact, Yand GT-activated DCs were extremely and equally potent in triggering a prompt expansion of Candida-specific or naive T lymphocytes, with no need for additional maturation treatments and in the absence of exogenously added IL-2. No significant difference in efficiency of antigen presentation or T cell activation was noticed between Y-or GT-matured DCs, as shown by an equal capacity to stimulate high-level proliferation in autologous CD4ϩ T cell clones specific for a major Candida antigen, MP-F2 [4] . More importantly, regardless of the different cytokine expression, Y-and GT/H-activated DCs could efficiently prime naive T lymphocytes for an allogeneic response and clearly induced a typical Th1-type polarization in these cells. In fact, CB-T cells, expanded by Y-or GT/Hmatured DCs, were able to secrete IFN-␥ and IL-2 but not IL-4, IL-10, or TGF-␤. The ability of Y-and GT/H-activated DCs to drive T cells into the Th1 phenotype likely reflected their elevated secretion of the Th1-promoting cytokine IL-12.
The different ability by Y and GT/H cells for IL-10 induction is, however, intriguing, as this cytokine can potently modulate DC functions [12, 42] . In particular, Candida-activated, IL-10-producing DCs have been shown to expand in vivo Tregs, which down-regulate antifungal Th1 reactivity in mice with gastrointestinal candidiasis [43] . In our in vitro model of T cell priming, we did not find any gross evidence for preferential induction of Treg cells by GT-activated DCs, as indirectly judged from enumeration of T cells preferentially expressing IL-4, IL-10, or TGF-␤, i.e., the cytokines typically produced by Treg cells [12, 44] . Nevertheless, it cannot be excluded that GT and H cells, by preferentially inducing IL-10 expression in human DCs, might play a role in triggering anti-Candida-regulatory T cell responses in vivo, which in turn, may suppress or attenuate endogenous Th1 immunity. This, however, might not necessarily imply immunoevasion, given the fact that Tregs have been shown to be beneficial rather than detrimental to the host in experimental murine candidiasis [43] . Besides T cell differentiation and activation, differential cytokine secretion by Y-and GT-stimulated DCs may also be involved in other function of DCs, such as the stimulation of B or natural killer lymphocytes [45, 46] , and clearly deserves further investigation.
In a recent report, Fè d' Ostiani et al. [20] have suggested that formation of GT and H cells in the course of experimental murine candidiasis may modulate the activation of DCs as to induce an inefficacious, primary, antifungal T cell response. In fact, murine DCs exposed to Y cells secreted IL-12 and primed protective Th1 responses, in vivo and in vitro, whereas Hexposed DCs produced IL-4 and no IL-12 and primed nonprotective Th2 cells [20] . Our finding that both fungal forms similarly activate human DCs for IL-12 production and Th1-type polarization of naïve T lymphocytes does apparently contrast with this study. It is noteworthy that "myeloid" murine DCs, as a prevalent DC subpopulation in the spleen or as a murine DC line, were prevalently analyzed by Fè ď Ostiani et al. and others [20, 47, 48] . This murine DC subset is considered a poor IL-12 producer, which preferentially induces Th2-oriented responses in CD4ϩ T cells [47, 48] . Other murine "nonmyeloid" DC subpopulations have been found to be unable to discriminate between the different fungal forms, in terms of IL-12/IL-4 production [43] . Conversely, monocytederived, human DCs are functionally biased for efficient IL-12 production and Th1-type lymphocyte priming, as compared with other known human DC subsets, although are also able, when properly activated, to drive Th2 cell differentiation [47, 48] . Therefore, differences in species and subtype of the DC populations analyzed may explain the discrepancy between the two studies, suggesting that the ultimate nature of DC functional activation by Y or GT/H cells may be predominantly dictated by the specificity of the responder DCs. The specific repertoire of Candida-recognizing receptors expressed by distinct DC species and/or subsets might determine the responsiveness of a given DC population to each fungal form. In fact, recognition of C. albicans by DCs involves a number of distinct surface receptors, including the MR, the CR3, the DC-specific intercellular adhesion molecule-3-grabbing nonintegrin molecule, the recently described ␤-glucan receptor dectin-1, and the Toll-like receptor 2 [36, 49, 50] , whose interplay may differently regulate DC activation in response to the fungus.
Human monocyte-derived DCs are "model" DCs, which cannot be identified with any naturally occurring, human DC population. Nevertheless, for most phenotypic and functional characteristics, these cells are considered representative of immature, dermal, or interstitial antigen-capturing DCs of skin and lymphoid organs [8, 48] . Our study demonstrates that the encounter of these cells with Y or GT cells of C. albicans leads to efficient processing of fungal cells for antigen presentation, stimulates the maturation of DCs, and induces DC functional competence for priming a Th1-type polarization in naive T lymphocytes. Although in vitro studies are inevitably reductive and may not reflect DC reactivity in the different in vivo settings, our findings strongly suggest that in vivo, Y-or GT-presenting, human DCs can efficiently recall fungus-specific T cell memory responses and also initiate primary, highly protective CD4ϩ Th1-type anti-Candida immunity.
On their early encounter with the fungus, DCs of unprimed individuals are likely to experience both forms of the fungus, as C. albicans rapidly develop GT and H cells when in contact with serum or body fluids [15] . The finding that Y or GT cells can license DCs for Th1-type priming fits well with the observation that natural immunization with C. albicans induces in humans the onset of a strongly Th1-polarized T cell immunity. [3, 4, 15, 27] . Our results are also in line with the recent observation that highly polarized, Th1-type, Candida-specific vaginal lymphocytes are quite predominating, not only in healthy women but also in patients suffering from recurrent vaginal candidiasis, a pathology that is typically characterized by a massive invasion of vaginal tissue by GT/H-form Candida cells [51] .
Formation of GT/H cells in vivo is believed to contribute to fungal virulence by suppressing Th1-type host reactivity or by inducing nonprotective Th2-type immunity, a notion mainly founded on experimental work in animal models of disseminated Candida infection [1, 2, [17] [18] [19] [20] . Data presented here indicate that GT/H formation is insufficient per se to directly modulate DC functional differentiation for weakening protective, antifungal defense in the human host. This, however, might be achieved by other mechanisms, including antigenic variations or expression/induction of immunosuppressive molecules, and by interaction with other immunocompetent cells [1, [17] [18] [19] 41] .
